InMed gets Nasdaq notice on min equity
InMed received notice that shareholders' equity fell below $2.5M due to merger expenses. The company expects to regain compliance upon closing the Mentari merger in Q4 2026.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
InMed received notice that shareholders' equity fell below $2.5M due to merger expenses. The company expects to regain compliance upon closing the Mentari merger in Q4 2026.
BPGC Acquisition Corp amended its charter to extend the deadline to consummate a business combination from March 2025 to March 16, 2028. The amendment requires triggering events to…
The Federal Reserve Board has terminated enforcement actions taken against SNB Bancshares and its subsidiary Bank of Eufaula.
Federal Reserve issues enforcement actions against former employees of Northstar Bank, American Express, and Regions Bank.
The FDA approved Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for pediatric patients with MPS IIIA, also known as Sanfilippo syndrome type A.
Hub Group received a Staff Delisting Determination for missing quarterly and annual reports. The company plans an appeal to stay delisting pending compliance.
Graphene & Solar Technologies announced its common stock commenced trading on the OTCQB Venture Market on September 15, 2026. This tier upgrade complements the company's U.S. silic…
Azo AI Holdings amended its Series A Preferred Stock certificate to remove non-Corporation tender offers from the definition of a Fundamental Transaction, altering shareholder prot…
Expand Energy filed a Second Supplemental Indenture dated Sept 17, 2026, with Regions Bank as trustee, modifying the terms of its 5.650% Senior Notes due 2031. This filing addresse…
Campbell's Company agreed to extend the termination date of its Five-Year Credit Agreement to April 16, 2031. This amendment provides additional liquidity access for the company.
DarkHorse Technologies Inc. has filed Articles of Continuation with British Columbia officials, moving its incorporation date back to September 16, 2026, creating a 'deemed' contin…
Faraday Future regains compliance with Nasdaq's equity standard and strengthened its balance sheet by reducing liabilities by approximately $20 million. EAI robot shipments have re…
MIRA Pharmaceuticals submitted the Phase 2a protocol for Ketamir-2 to IRB after FDA review, targeting site initiation in Q1 2027 to evaluate efficacy in chemotherapy-induced periph…
Aquestive Therapeutics announced the resubmission of its New Drug Application (NDA) for Anaphylm (dibutepinephrine) sublingual film to the U.S. FDA for the treatment of Type I alle…
Globaltech has applied for a Nasdaq Capital Market listing but awaits approval. The company also completed a reverse split to meet listing requirements.
The Federal Reserve has formally issued its latest meeting statement.
The Federal Reserve Board and Federal Open Market Committee released preliminary economic projections from the September 15-16 FOMC meeting.
Clene Inc. engaged Dorsey & Whitney LLP to opine that the recently issued common stock shares are validly issued and fully paid. This legal opinion is submitted as an exhibit to th…
Sturm Ruger & Co. Inc. amended its rights agreement to accelerate the final rights expiration date to September 16, 2026. The amendment does not invoke the rights of shareholders.
Altus Group U.S. Inc. provided a consent to refer to their role in Ares Real Estate's valuation process for the August 31, 2026 NAV per share. The consent enables the reference to …